News for Microbot Medical Inc. (MBOT)

The addition of a seasoned VP of Marketing compliments the recent hiring of the Company's VP of Sales to establish its commercialization readiness infrastructur

**media[582760]**

Mr. Paul Mullen Most Recently Served as the Director of Sales at Inari Medical which was Acquired by Stryker Corporation Earlier This Year This Appointment Rep

**media[556936]**

Research Collaboration demonstrates the feasibility of using the LIBERTY® Endovascular Robotic System between separate and remote facilities in a coronary sim

**media[538179]**

Microbot Medical announces $13 million registered direct offering and private placement to fund development of LIBERTY Robotic System and IP portfolio.

**media[536663]**

BRAINTREE, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. ( MBOT) today announced that it has entered into definitive agreements for the purch

The stock of Haemonetics Corporation (HAE) experienced a notable decline, dropping 5.06% to $59.80 per share. The trading volume reached 1.465 million shares, w

BD (BDX), a leading medical device company, experienced a significant stock movement with a 5.02% drop in its share price, reaching $232.77. The trading volume

We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Microbot Medical Inc (NASDAQ:MBOT) stands against...

Diginex Limited is up over 107 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Operations Leader to Enhance Operational Efficiencies by Managing Production Scale-up and Cost Reduction Activities to Support Commercialization BRAINTREE, Ma

American Blood Technologies (HAE) experienced a notable stock decline of 5.20%. The stock is currently priced at $75.81 per share, with a trading volume of 218,

AtriCure (ATRC) experienced a notable stock price increase of 5.04%, reaching $36.44, with a trading volume of 258,045 shares and a turnover rate of 0.53%. The

BRAINTREE, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. ( MBOT) today announced the closing of its previously announced registered direct of

Microbot Medical announces $8.6 million registered direct offering priced at-the-market under Nasdaq rules.

HINGHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. ( MBOT) today announced the closing of its previously announced registered direct offe